Translation Together envisions a global translational research community of diverse stakeholders empowered to effectively and efficiently translate discoveries into health interventions for the benefit of patients and society.
Advancing the science and understanding of biomedical translation through global collaboration.
Coordinate and develop programs and resources for educating and training the next generation of translational scientists and other key stakeholders.
Advocate for a broad understanding of and appreciation for translation and translational science among diverse stakeholders.
Assist investigators in the conduct of translation and translational science by connecting them to resources, tools, technologies, and expertise.
Conduct collaborative research projects to remove systemic barriers and catalyze translation.
AdMare BioInnovations is Canada’s Global Life Sciences Venture, building the Canadian life sciences industry from sea to sea.
We do this by sourcing therapeutically and commercially promising research from leading academic and biotech partners to create new companies of scale, providing specialised expertise, infrastructure, and capital to help existing companies scale up, and driving the growth of those companies into Canadian anchors by training the next generation of highly-qualified personnel.
LifeArc drive medical innovation through their our own research and work with a range of partners from industry, charities, universities, research organisations and others involved in improving lives for patients.
They have a 25-year legacy of collaborating with scientists on diagnostics and therapies, enhancing and protecting innovation and advancing promising research.
LifeArc focuses on translation – progressing work from early lab-based findings through to development and a point where it can be used in patients. By working in this way, they play a key role in developing new treatments, medicines, diagnostics, technologies or information resources, and in helping to turn research into practical products that benefit patients.
National Center for Advancing Translational Sciences
The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) was officially established in fiscal year 2012 to transform the translational science process so that new treatments and cures for disease can be delivered to patients faster. NCATS, one of 27 Institutes and Centers (ICs) at NIH, strives to develop innovations to reduce, remove or bypass costly and time-consuming bottlenecks in the translational research pipeline in an effort to speed the delivery of new drugs, diagnostics and medical devices to patients.
Therapeutic Innovation Australia (TIA) is a national consortium of translational research infrastructure. Through TIA, Australian researchers from the public and private sector can access a range of expertise and services to assist in the development of new therapeutic products. The TIA Consortium includes national and international expertise in the development of small molecule pharmaceuticals, biologics & vaccines and cell & gene therapies.
The Oswaldo Cruz Foundation (Fiocruz) is the most prominent Institution of Science and Technology in Health in Latin America. Bound to the Ministry of Health, its mission is to produce, disseminate and share knowledge and technologies, aiming at strengthening and consolidating the Brazilian Public Health System and the promotion of health and quality of life for the population. The Foundation works in all public health stages, from basic research and health care to innovation and production of supplies, such as vaccines, diagnostic kits, and drugs.
The Japan Agency for Medical Research and Development (AMED) promotes integrated research and development in the field of medicine, from basic research to clinical trials. Their goal is to fast-track medical R&D that directly benefits people, not only by extending lifespans but also by improving the quality of life.
EATRIS is the European research infrastructure for translational medicine. The organisation provides research services for biomedical innovation by providing fast, tailored access to cutting-edge enabling technologies in translational research.
Via the EATRIS central hub, you can access the vast array of clinical expertise and high-end facilities that are available within the 100+ top-tier academic centres across Europe.